International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: 10.5281/zenodo.14211007
Original Research Article
A Study of Uterine Scar Dehiscence and Rupture in Post-Cesarean Pregnancies: Maternal and Neonatal Outcomes
Published
Nov. 24, 2024
Abstract

Background: Uterine scar complications following cesarean delivery represent significant obstetric challenges with potentially severe maternal and neonatal consequences. Objective: To evaluate the incidence, risk factors, and outcomes of uterine scar dehiscence and rupture in post-cesarean pregnancies. Methods: A prospective observational study of 120 women with previous cesarean sections was conducted at a tertiary care center from January to December 2023. Participants underwent standardized antenatal monitoring including serial ultrasonographic assessment. Results: Scar complications occurred in 8.33% (n=10) cases. Short inter-pregnancy interval (<18 months) (adjusted OR 3.8, 95% CI 1.9-7.6, p<0.001) and multiple previous cesareans (adjusted OR 3.2, 95% CI 1.7-6.1, p<0.001) were significant risk factors. Emergency cesarean delivery was required in 90.0% of complicated cases. LUS thickness <2.0mm was associated with higher complication rates (60.0% vs 5.5%, p<0.001). NICU admission rates were significantly higher in complicated cases (40.0% vs 7.3%, p<0.001). Conclusion: Close monitoring of post-cesarean pregnancies, particularly those with identified risk factors, is crucial for optimal outcomes. Ultrasonographic assessment of LUS thickness provides valuable predictive information.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
1954 Views
398 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved